To frame up how the Biotech IPO markets have evolved over the past six years, the author reviews data around the changes to pre-money valuations over time. The trend line is clear: up and to the right
Category: NASDAQ:XBI
The Incredible Expanding Universe of Biotech Stocks
The biotech sector is unique relative to the rest of the stock market in many ways, but one that is often overlooked: its expansionary public equity market footprint.
